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Summary
Wide-spectrum caspase inhibition by the baculoviral
p35proteinwaspreviouslyshown tobeaconsequence
of covalent inhibition in which a thioester bond is sta-
bly formed between the cleavage residue Asp87 of
p35 and the active site Cys3600 of caspase-8. Here we
show that the N-terminal fragment of cleaved p35
(p35-N) is a circular peptide when dissociated from
the caspase. Biochemical and crystallographic data
suggest that p35-N circularization results from the
trapping of a native chemical ligation intermediate in
the p35/caspase complex, in which the N-terminal
Cys2 of p35 attacks the Asp87-Cys3600 thioester to
form an equilibrium between Asp87-Cys2 and Asp87-
Cys3600. This provides a crucial covalent interaction
for keeping theN terminus of p35 bound in the caspase
active site, which explains the absolute requirement of
Cys2 for caspase inhibition. Participation of native
chemical ligation in caspase inhibition by p35 illus-
trates an unusual mechanism of protease inhibition.
Introduction
Caspases are central effectors of apoptotic cell death.
The p35 protein from baculoviruses is an effective cas-
pase inhibitor that prevents host cell death and contrib-
utes to the pathogenesis of the viral infection [1–4].
Unlike many protein caspase inhibitors, p35 is a wide-
spectrum caspase inhibitor against most, if not all,
groups of caspases and blocks apoptosis induced by
numerous stimuli and in diverse organisms [3, 5, 6].
These studies have demonstrated that p35 can rescue
cells from apoptosis and enable them to revive their nor-
mal cellular functions, thereby establishing its promise
for controlling apoptosis in degenerative diseases.
The p35 protein contains a solvent-exposed and
highly protruding reactive site loop (RSL) that harbors
a caspase recognition sequence (DQMD87) [7], and cas-
pase inhibition by p35 correlates with the cleavage at
Asp87 by the caspase [1–3]. Our crystal structure of the
postcleavage complex between p35 and caspase-8 (see
Figure S1A in the Supplemental Data available with this
article online) revealed that caspase-8 is inhibited by
p35 via a covalent thioester linkage between the active
site Cys3600 of caspase-8 (prime [0] is used to denote res-
idues in caspase-8) and the cleavage residue Asp87 of
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physics, Columbia University, New York, New York 10032.p35 [8]. During normal substrate cleavage, a water mol-
ecule is activated by the active site His3170 of caspase-8
to quickly hydrolyze the thioester intermediate. In the
p35/caspase-8 complex, the thioester bond is pre-
served by the N terminus of p35, which interacts with
the caspase active site to exclude solvent. Prior to cas-
pase cleavage, the N terminus of p35 is buried in the
core of the structure and its repositioning into the cas-
pase active site is realized through a series of dramatic
postcleavage conformational changes [8, 9] (Figures
S1B and S1C). Structure-based mutational studies
have shown that the two N-terminal residues of p35 in
direct contact with the caspase, Cys2 and Val3, are crit-
ical for caspase inhibition by p35 [8, 10, 11].
The covalent interaction between p35 and the cas-
pase provides a framework for understanding the effi-
cient and wide-spectrum inhibition of caspases by
p35, in which the substrate recognition sequence in
the RSL acts as the ‘‘bait’’ for a caspase and the N ter-
minus is required to stabilize the complex and ‘‘kill’’ the
caspase. However, we were intrigued by a number of
unexplained observations. Specifically, residue Cys2
of p35, which is the N-terminal residue in the mature
protein, has to be a Cys, as C2G, C2A, and the con-
served isosteric C2S mutations all abolish its inhibitory
activity [8, 10, 11]. In contrast, a conservative mutation
V3I remains active [10]. In addition, the required interac-
tion between the N terminus of p35 and the caspase
buries an exceptionally small surface area (w140 A˚2/
partner), which is paradoxical to the apparent strength
of the inhibition. Finally, the electron density map is con-
tinuous from Asp87 to Cys2, which is inconsistent with
absence of a covalent bond between the two residues
in the original structure.
Here we show that although the N terminus of p35 is
not blocked before complex formation with caspase-8,
the postcleavage N-terminal fragment of p35 (p35-N,
residues 2–87) becomes completely resistant to N-
terminal sequencing and therefore appears ‘‘blocked.’’
We demonstrate that this resistance to sequencing
occurs because p35-N dissociates from the caspase
as a circular peptide. This circularization is highly sug-
gestive of a native chemical ligation reaction [12] in
which the free N-terminal Cys2 attacks the thioester
bond at Asp87 (Asp87-Cys3600), leading to reversible
trans-thioesterification followed by a spontaneous irre-
versible S0N acyl shift and the formation of a peptide
bond between Asp87 and Cys2. However, in the native
p35/caspase-8 complex, both biochemical and struc-
tural observations clearly indicate a covalent linkage
between p35 and its target caspase, and therefore do
not support p35-N existing as an already circularized
peptide in the complex. Instead, the data suggest that
the native p35/caspase-8 complex traps an intermedi-
ate of the native chemical ligation reaction, in which
reversible trans-thioesterification leads to an equilib-
rium between formation and breakage of two thioester
bonds, Asp87-Cys2 and Asp87-Cys3600. Importantly,
in this complex, the N-terminal amino group is sterically
hindered from attacking the Asp87-Cys2 thioester,
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Upon denaturation, however, the thioester becomes ac-
cessible to the Cys2 amino group and rearranges to
form the circular peptide. This revised model of caspase
inhibition by p35 reveals that the N terminus of p35 uti-
lizes a covalent mechanism to remain in the caspase
active site and contributes to caspase inhibition. It
explains each of the intriguing and unexplained obser-
vations described above and provides additional novel
insights into caspase inhibition by p35 as well as prote-
ase inhibition in general.
Results
p35 Becomes Resistant to N-Terminal
Edman Sequencing after Complex
Formation with a Caspase
Ever since the original report on the caspase inhibitory
activity of p35, it has been noted that p35 could not
undergo N-terminal Edman sequencing [1, 3, 8, 11].
Although these experiments were performed on the
p35-N fragment after p35 forms a complex with and
gets cleaved by a target caspase, it was assumed that
the N terminus of full-length p35 is also blocked, for
example, by acetylation.
Our site-directed mutational studies showed that p35
mutations such as C2S completely abolished the inhib-
itory activity of p35 against caspase-3 or caspase-8 and
prevented the formation of a covalent complex with ei-
ther of the target caspases [10]. Because the N terminus
of p35 directly contacts the caspase active site and
N-terminal modifications often vary with the nature of
the N-terminal residue, we performed N-terminal se-
quencing on the C2S mutant to determine whether its
N terminus is still blocked and whether the mutational
effect may be due to a change of N-terminal modifica-
tion. To our surprise, the C2S mutant of full-length p35
could be N-terminally sequenced (Table 1), indicating
that the N terminus is not blocked. In addition, to our
further surprise, even wild-type full-length p35 could
be N-terminally sequenced, demonstrating the absence
of covalent modification that prevents Edman degrada-
tion. Therefore, the earlier assumption that the N termi-
nus of p35 is modified is incorrect. Rather, it is the
p35-N fragment generated after complex formation
with a caspase that is resistant to N-terminal sequenc-
ing (Table 1). This resistance is not simply due to cas-
pase cleavage, because the C2S mutant of p35 can still
be cleaved by caspase-8 but its p35-N fragment is not
resistant to Edman sequencing.
Native Chemical Ligation Chemistry in Caspase
Inhibition by p35: The p35-N Fragment Is a
Circular Peptide
The resistance of p35-N, but not p35, to Edman se-
quencing is intriguing. Because the thiol side chain of
the N-terminal Cys2 residue is absolutely required for
caspase inhibition by p35, we contemplated the possi-
bility that the thiol group may participate in a chemical
reaction that is required for both the stabilization of
the postcleavage p35/caspase complex and the modi-
fication of the p35 N terminus.
In the p35/caspase-8 complex, the cleavage residue
Asp87 of p35 is linked to the active site Cys3600 ofcaspase-8 via a thioester bond, which is protected
from hydrolysis due to elimination of solvent accessibil-
ity by the N terminus of p35 [8]. The repositioning of the
N terminus of p35 into the active site could allow the thiol
side chain of Cys2 to attack the thioester bond in the
same fashion that would occur in native chemical liga-
tion [12, 13]. Two steps are involved in native chemical
ligation. First, the thiol of an N-terminal Cys residue at-
tacks a C-terminal thioester, leading to a reversible
trans-thioesterification. Second, the free amino termi-
nus attacks the thioester to induce an irreversible
S0N acyl shift, leading to formation of a peptide bond
between the C-terminal residue of the thioester and
the attacking N-terminal Cys. For the p35-N fragment,
such a reaction would produce a circular peptide by link-
ing Asp87 and Cys2 via a peptide bond and would ex-
plain the consequent resistance of p35-N to Edman
sequencing.
To determine whether wild-type p35-N is circular, we
first attempted mass spectrometry analysis of tryptic
fragments of p35-N. Although the masses of the ob-
served fragments are consistent with the sequence of
p35-N, a crucial anticipated fragment, corresponding ei-
ther to a linear p35-N (residues Cys2–Arg20) or to a circu-
lar p35-N (residues Asp81–Arg20), could not be recov-
ered. We therefore took an alternative approach using
cyanogen bromide (CNBr) digest and Edman N-terminal
sequencing. We subjected the p35/caspase-8 complex
to SDS-PAGE followed by blotting onto a PVDF mem-
brane (Figure 1A). The protein band corresponding to
p35-N was excised and submitted for N-terminal se-
quencing, with and without pretreatment by CNBr that
cleaves proteins after Met residues (Figure 1B).
As expected, N-terminal sequencing of p35-N without
CNBr treatment did not yield any amino acids (Figure 1C).
With CNBr treatment, if p35-N is a circular peptide,
a unique sequence of D87-C2-V3-I4-F5-P6-V7 should
be revealed. Indeed, this sequence was clearly present
in the N-terminal sequencing reaction of CNBr-treated
p35-N, in addition to the expected N termini from
other regions of p35-N (Figures 1D–1F; Table 1). This
Table 1. Edman Sequencing of p35 and p35-N
p35 or Its Fragment p35-N Edman Sequencing
p35
Wild-type Sensitive
C2S Sensitive
p35-N
Wild-type Resistant
C2S Sensitive
Wild-type, 10 mM DTT Resistant
Wild-type, 100 mM DTT Resistant
Wild-type, 10 mM cysteine Resistant
Wild-type, 100 mM cysteine Resistant
p35-N with CNBr Treatment
Fragment D87–V7 Present
Fragment N36–P42 Present
Fragment M46–P52 Present
Fragment F47–I53 Present
Protein expression and purification were performed as described
previously [8, 10]. All Edman sequencing experiments were per-
formed on an Applied Biosystems Procise 494/HT protein se-
quencer (Foster City, CA), with cyanogen bromide (CNBr) digestion
performed similarly as described previously [16].
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(A) SDS-PAGE of p35/caspase-8 complex, showing the band corre-
sponding to p35-N. p35-C is the C-terminal fragment of cleaved
p35, and p18 and p12 are the large and small subunits of cas-
pase-8, respectively.
(B) Sequence of p35-N (residues 2–87) and expected CNBr treat-
ment fragments if p35-N is circular. Residue numbers for selected
residues are labeled.
(C) Chromatogram for the first cycle of Edman sequencing of p35-N.
(D) Chromatogram for the first cycle of Edman sequencing of CNBr-
treated p35-N. Asp87 will only be present if p35-N is circular be-
cause otherwise it would have been released during CNBr digest.demonstrates that p35-N is circular, linked via a peptide
bond between Asp87 and Cys2.
Although p35-N is circular upon dissociation from the
caspase, the native p35/caspase-8 complex appears to
trap an intermediate in the first step of native chemical
ligation, which leads to p35-N circularization upon com-
plex denaturation and dissociation. In such an inter-
mediate, the thiol group of Cys2 would react with the
Asp87-Cys3600 thioester to establish an equilibrium be-
tween the Asp87-Cys2 and Asp87-Cys3600 thioesters.
Notably, in native chemical ligation reactions, formation
and breakage of the equivalent thioesters are reversible.
To exclude the possibility that generation of the circu-
lar peptide takes place in solution after denaturation via
an attack of Cys2 on the Asp87-Cys3600 thioester, we
used high concentrations of free thiols to compete
with the reaction. We treated the p35/caspase-8 com-
plex with 10 mM or 100 mM dithiothreitol (DTT) or cyste-
ine in SDS buffer, boiled the samples for 10 min, sepa-
rated the samples on an SDS-PAGE, and blotted the
samples to a PVDF membrane. The p35-N bands re-
mained resistant to Edman sequencing even at 100 mM
DTT or cysteine (Table 1), showing that the circulariza-
tion was not inhibited by free thiols. This suggests that
the Asp87-Cys2 thioester intermediate is already formed
in the native p35/caspase-8 complex, which is trapped
because the acyl shift required for peptide bond forma-
tion in the second step of the reaction is prevented, as
described below.
Continuous Electron Density Supports Covalent
Interaction between the p35 N Terminus and
Residue Asp87 in the Native p35/Caspase-8
Complex
The crystal structure of the p35/caspase-8 complex [8]
supports the presence of a covalent interaction between
the p35 N terminus and the p35 cleavage residue Asp87,
as would be expected in a trapped thioester intermedi-
ate state of native chemical ligation. The p35/caspase-
8 structure was originally determined by molecular re-
placement using uncleaved p35 and caspase-8 as
models [7, 8]. Based on the initial electron density map,
calculated without the region of the RSL around the
cleavage residue Asp87 (D81–95) and with the N-terminal
residues still buried in the core of p35, and a simulated
annealing omit electron density map, Asp87 is clearly
connected to both Cys3600 of caspase-8 and Cys2 at
the N terminus of p35. Although the continuity of the elec-
tron density at 3.0 A˚ resolution does not unambiguously
demonstrate the covalent interaction, the combined bio-
chemical and crystallographic data compellingly indi-
cate the existence of a thioester bond between Asp87
and Cys2. Indeed, the electron density can be easily
modeled as the equilibrium between Asp87-Cys2 and
Asp87-Cys3600 thioester bonds (Figures 2A and 2B).
(E) Chromatogram for the second cycle of Edman sequencing of
CNBr-treated p35-N, showing the presence of an acrylamide deriv-
ative of Cys (labeled as Cys*).
(F) Chromatogram for the third cycle of Edman sequencing of CNBr-
treated p35-N.
In (D)–(F), amino acid residues in each of the four expected CNBr-
derived fragments are labeled.
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120Figure 2. Stereo Diagrams of Modeled Reversible Trans-Thioesterification, the Native Chemical Ligation Intermediate Trapped in the p35/Cas-
pase-8 Complex
The thioesters, Asp87-Cys3600 (A) and Asp87-Cys2 (B), are shown in stick models with several adjacent residues and superimposed with the
simulated annealing omit map contoured at 1s. Selective residues are labeled in magenta and blue for caspase-8 and p35, respectively. Note
the continuity of the electron density from Asp87 to Cys2 of its N terminus and to Cys3600 of caspase-8.The Native p35/Caspase-8 Complex Prevents
Irreversible Acyl Shift and Completion
of the Native Chemical Ligation Reaction
Analysis of the crystal structure of the p35/caspase-8
complex reveals that once attacked by the thiol of
Cys2, the carbonyl carbon of Asp87 is no longer acces-
sible to the free amino group of Cys2. This makes the
free amino group sterically unable to attack the Asp87-
Cys2 thioester, much in the same way that water is un-
able to attack the Asp87-Cys3600 bond. Because attack
by the free amino group induces the S0N acyl shift,
which is absolutely required for the second step of the
chemical ligation reaction, steric hindrance of such an
attack explains why circularization of p35-N cannot pro-
ceed within the complex, and only occurs upon complex
denaturation.
Discussion
The discovery that p35-N is a circular peptide reveals the
involvement of native chemical ligation chemistry in cas-
pase inhibition by p35. In this model, three chemical
steps are involved in the formation and dissociation of
the p35/caspase complex (Figure 3). First, a target cas-
pase recognizes the substrate sequence in the RSL of
p35. The active site Cys of the caspase (Cys3600 in cas-
pase-8) forms a thioester intermediate with the cleavageresidue Asp87. The portion of the RSL beyond Asp87
dissociates from the caspase, leading to dramatic con-
formational changes in p35. Second, as a result of the
p35 conformational change, the previously buried p35
N terminus is liberated and finds its way into the active
site of the caspase. There, a native chemical ligation re-
action involving the Asp87-Cys3600 thioester and the N-
terminal Cys2 is trapped at the thioester equilibrium in-
termediate step. At this point, Asp87 is inaccessible to
the free amino group of p35-N, preventing p35-N circu-
larization. The Asp87-Cys2 thioester provides a crucial
covalent interaction for keeping the N terminus of p35
in the caspase active site. Finally, upon denaturation of
the p35/caspase complex, the free amino group of
Cys2 is able to participate in the S0N shift required
for peptide bond formation between Asp87 and Cys2.
This model explains each of the three previously unex-
plained intriguing observations on caspase inhibition
by p35: (1) the absolute requirement for Cys2, (2) the
continuous electron density from Asp87 to Cys2, and
(3) the exceptionally small surface area of interaction at
the p35 N terminus.
Previously we, as well as others, have shown that un-
der mild SDS treatment in the absence of reducing agent
and at lower pH, p35-N is present both as an SDS-stable
adduct with the large subunit of the caspase and as a
dissociated peptide [8, 11]. It is likely that in these
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121Figure 3. Native Chemical Ligation in the Native and Denatured States of the p35/Caspase-8 Complex
Residue numbers are labeled to the top right or bottom right of each atom, and hydrogen atoms are omitted from the diagram. Caspase-8 is
shown by filled rectangles, while p35 is shown by open rectangles. Curved lines represent the protein sequences between Cys2 and Asp87 in
p35-N. In the native state, the free amino group at the N terminus of p35-N is inaccessible to Asp87.SDS-PAGE samples, the partition between the adduct
and the isolated p35-N is reflective of the native thioester
equilibrium between the p35-N/caspase thioester and
the p35-N circular thioester that rearranges to form a cir-
cular peptide. Consistent with this observation, the p35-
N band in these mildly treated samples is also resistant
to Edman sequencing and is circular (data not shown).
If in the p35/caspase complex the thioesters between
Asp87 and Cys3600 or Cys2 are in equilibrium, why is it
that the complex does not fall apart when the Asp87-
Cys3600 bond breaks transiently and why does the N ter-
minus not leave the active site when the Asp87-Cys2
bond breaks transiently? Presumably the fast rate of
the reversible chemical reaction disallows dissociation
of either the N terminus or the caspase recognition se-
quence of p35 from the caspase active site. These p35
segments are temporarily held in place, albeit weakly,
by noncovalent interactions. However, the inhibitory re-
action does exhibit leakage, in which dissociation of
a fraction of the complexes may occur stochastically [3].
Because the Asp87-Cys2 and Asp87-Cys3600 thioest-
ers interconvert through a tetrahedral intermediate, is it
possible that this is the trapped state in the p35/cas-
pase-8 complex? Our experimental data do not distin-
guish this possibility from the thioester equilibrium
because both would have been consistent with the con-
tinuity of the electron density. The choice of thioester
equilibrium over tetrahedral intermediate is based pri-
marily on what we know about protein structure and
function. Proteins do not appear to have the ability to
stabilize tetrahedral intermediates of any kind, and
a stable tetrahedral intermediate has never been ob-
served in any crystal structure. The closest example
might be the cryogenic trapping of a transient tetrahe-
dral intermediate in the hydrolysis of the acyl-enzyme
complex of elastase with b-casomorphin-7, in which
the tetrahedral state lasts less than 2 min after initiation
of the reaction [14].
Significance
Native chemical ligation chemistry is now frequently
used in vitro as a semisynthetic technique to ligate
peptide segments containing fluorophores, stable iso-
topes, or unnatural amino acids to recombinantly ex-
pressed proteins via a peptide bond [12, 13]. In vivo,native chemical ligation is utilized as part of the chem-
istryofposttranslationalproteinsplicing, anaturalpro-
cess identified in many organisms [15]. In protein
splicing, an intein in a polypeptide chain is excised
and two exteins upstream and downstream of the in-
tein are joined [15]. The revelation of a novel role for
native chemical ligation in caspase inhibition by p35
further demonstrates the power of this chemistry and
adds to our understanding of the wide repertoire of
modes of protease inhibition.
Supplemental Data
Supplemental Data include one figure and can be found with this
article online at http://www.chembiol.com/cgi/content/full/13/2/
117/DC1/.
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